24/7 SUPPORT  1.800.887.8100
`
`Visit HCP Site
`
`Prescribing Information
`
`Important Safety Information
`
`Sign in/Register
`
`Relapsing MS
`
`®
`Teva's COPAXONE
`
`®
`Taking Teva's COPAXONE
`
`®
`Shared Solutions
`
`Living With MS
`
`®
`Home > Shared Solutions
`
` > Financial Support
`
`FINANCIAL SUPPORT
`
`A A A
`
`Show Conversation
`
`Voice: On Off
`
`Ask me about starting treatment...
`
`®
`Teva's Shared Solutions believes that financial matters should not
`get in the way of your relapsing MS treatment
`
`®
`Teva's Shared Solutions is dedicated to helping you find affordable access to COPAXONE
`®
` therapy—we can assist you in searching for financial solutions so your financial concerns
`®
`don’t get in the way of starting or staying on COPAXONE .
`
`®
`COPAXONE Co-pay Solutions
`
`®
`Through COPAXONE Co-pay Solutions , if eligible, your co-pay for 3-times-a-week
`®
`‡
`COPAXONE 40 mg could be lowered to $0 per month out of pocket. Terms and
`®
`Conditions apply. Call Teva's Shared Solutions for information about COPAXONE Co-pay
`®
`®
`†
`Solutions for daily COPAXONE 20 mg.
`
`FREE WELCOME KIT
`Receive tools and
`ongoing support when
`you join.
`
`®
`TEVA'S COPAXONE
`
`Be Bold.
`Be proactive about
`your prescription.
`
`®
`If you have insurance and would like to find out more about COPAXONE Co-pay Solutions
`, call Teva's Shared Solutions today at 1-800-887-8100. Make sure you have your
`insurance card, prescription card, and income information available when you call.
`
`No financial qualification and no paperwork required
`
`If your commercial prescription insurance has recently changed, Teva's Shared
`®
`®
`Solutions to see if you are eligible for COPAXONE Co-pay Solutions
`
`Your Case Manager: Your partner for personalized financial solutions
`
`Your Case Manager can help you with:
`
`®
`Benefits investigation, to see if your plan covers Teva's COPAXONE
`
`Pharmacy benefits research, to help determine the most convenient way for you to
`®
`receive Teva's COPAXONE
`
`MYLAN PHARMS. INC. EXHIBIT 1126 PAGE 1
`
`

`
`Assistance with understanding your insurance benefits and any changes that can
`affect your coverage
`
`Assistance with navigating Medicare Part D
`
`Additional support depending on your insurance coverage or financial need
`
`®
`®
`Teva's Shared Solutions can help you maintain access to COPAXONE therapy
`
`®
`Let the Case Managers at Teva's Shared Solutions help you find the financial solutions
`®
`you need to start and stay on Teva's COPAXONE . Whether you need help getting started
`on therapy, your financial situation or benefits have changed, or you may just be trying to
`understand federal health care policies, we can help.
`
`No matter what your needs are, we provide free, personalized service to help you gain
`access to therapy as soon as possible. That way you can focus on what matters most –
`realizing the benefits of therapy.
`
`Find answers to Frequently Asked Questions about insurance.
`
`®
`Hear what doctors think about Teva's Shared Solutions .
`
`Doctors have been compensated by Teva.
`
`®
`Shared Solutions
`
`|
`
`Training and Nurse Support
`
`back to top
`
` 
`
`Use:
`
`®
`COPAXONE (glatiramer acetate injection) is prescription medicine used for the treatment of people with relapsing forms of
`multiple sclerosis (MS).
`
`®
`IMPORTANT SAFETY INFORMATION ABOUT COPAXONE
`
`®
`Do not take COPAXONE if you are allergic to glatiramer acetate or mannitol.
`
`®
`Some patients report a short-term reaction right after injecting COPAXONE . This reaction can involve flushing (feeling of
`warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms
`generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the
`postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If
`symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives,
`skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the
`above occurs, do not give yourself any more injections until your doctor tells you to begin again.
`
`Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few
`®
`IMPORTANT SAFETY INFORMATION ABOUT COPAXONE (glatiramer acetate injection)
`SHOW MORE
`minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell
`®
`Do not take COPAXONE if you are allergic to glatiramer acetate or mannitol. Some patients report a short-term reaction right after injecting
`your doctor if you experience chest pain that lasts for a long time or feels very intense.
`®
`COPAXONE . This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety,
`and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific
`
`MYLAN PHARMS. INC. EXHIBIT 1126 PAGE 2
`
`

`
`treatment.
`A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local
`destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.
`
`®
`The most common side effects in studies of COPAXONE are redness, pain, swelling, itching, or a lump at the site of injection,
`®
`flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE . For a
`®
`complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE .
`
`You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-
`800-FDA-1088.
`
`®
`Please see full Prescribing Information for Teva’s COPAXONE .
`
`RELAPSING MS
`
`®
`TEVA'S COPAXONE
`
`®
`TAKING TEVA'S COPAXONE
`
`®
`SHARED SOLUTIONS
`
`LIVING WITH MS
`
`What is Relapsing MS?
`
`Relapsing MS Symptoms
`
`Relapsing MS Diagnosis
`
`Relapsing MS Treatment
`
`Talk to Your Doctor
`
`Financial Support
`
`Training and Nurse
`Support
`
`Educational Resources
`
`Virtual Health Assistant
`
`3-times-a-week
`®
`COPAXONE 40 mg
`
`®
`Your COPAXONE
`Prescription
`
`Be Proactive About Your
`Prescription
`
`A Therapy With Proven
`Results
`
`How to Start
`
`Preparation
`
`®
`Injecting with autoject 2 for
`glass syringe
`
`®
`Injecting with the COPAXONE
`Pre-filled Syringe
`
`Syringe Storage & Disposal
`
`Tolerability Profile
`
`Injection Tracking
`
`®
`How Teva's COPAXONE
`Works
`
`COPAXONE
`webTracker™
`
`®
`COPAXONE
`Perspectives
`
`Video Library
`
`Resources
`
`Travel Tips
`
`Live Event Locator
`
`Teleconferences
`
`Insurance FAQ
`
`Terms of Use | Accessibility Help | Privacy Notice | Site Map | Contact Us
`
`®
`Injections for 3-times-a-week COPAXONE 40 mg should be at least 48 hours apart.
`
`†
`
`®
`Applies only to daily COPAXONE 20 mg. Certain limits and restrictions apply.
`
`®
`®
`Terms and Conditions for daily COPAXONE include: COPAXONE Co-pay Solutions is open to both new and existing patients who are residents of the US or
`
`®
`Puerto Rico and who have commercial prescription insurance coverage for COPAXONE 20 mg. The offer is not valid for patients covered in whole or in part by
`
`Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of whether a specific prescription
`
`is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of
`
`any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void in Massachusetts and where otherwise prohibited by law,
`
`taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time
`
`without notice. This program is not health insurance.
`
`MYLAN PHARMS. INC. EXHIBIT 1126 PAGE 3
`
`

`
`††
`
`®
`Applies only to 3-times-a-week COPAXONE 40 mg. Certain limits and restrictions apply.
`
`®
`Terms and Conditions for 3-times-a-week COPAXONE include: COPAXONE Co-pay Solutions is open to both new and existing patients who are residents of the
`
`US or Puerto Rico and who have commercial prescription insurance coverage for COPAXONE 40 mg. The offer is not valid for uninsured patients or patients
`
`® ®
`
`covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of
`
`whether a specific prescription is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be
`
`consistent with the terms of any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void in Massachusetts and where
`
`otherwise prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or
`
`discontinued at any time without notice. This program is not health insurance.
`
`®
`®
`®
`COPAXONE , COPAXONE CO-PAY SOLUTIONS , and COPAXONE iTracker are registered trademarks of Teva Pharmaceutical Industries Ltd.
`
`®
`Shared Solutions is a registered service mark of Teva Neuroscience, Inc.
`
`COPAXONE webTracker™ is a trademark of Teva Pharmaceutical Industries Ltd.
`
`®
`autoject 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
`
`Apple and iTunes are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.
`
`Android and Google Play are trademarks of Google Inc.
`
`© 2015 Teva Neuroscience, Inc. COP-43010 This site is intended for US residents only.
`
`MYLAN PHARMS. INC. EXHIBIT 1126 PAGE 4